Search Results - "Natalia, Fadeeva"

Structure and State of Water in Branched N -Vinylpyrrolidone Copolymers as Carriers of a Hydrophilic Biologically Active Compound by Kurmaz, Svetlana V, Fadeeva, Natalia V, Ignat'ev, Vladislav M, Kurmaz, Vladimir A, Kurochkin, Sergei A, Emel'yanova, Nina S

“…Hydrated copolymers of -vinylpyrrolidone (VP) with triethylene glycol dimethacrylate as a promising platform for biologically active compounds (BAC) were…”
Get full text

New amphiphilic terpolymers of N-vinylpyrrolidone with poly(ethylene glycol) methyl ether methacrylate and triethylene glycol dimethacrylate as carriers of the hydrophobic fluorescent dye by Kurmaz, Svetlana V., Fadeeva, Natalia V., Komendant, Adelina V., Ignatiev, Vladislav M., Emelyanova, Nina S., Shilov, Gennady V., Stupina, Tatyana S., Filatova, Natalia V., Lapshina, Maria A., Terentyev, Alexei A.

“…New amphiphilic terpolymers of N -vinylpyrrolidone, poly(ethylene glycol) methyl ether methacrylate ( M n 500 g/mol) and triethylene glycol dimethacrylate…”
Get full text

Mesoporous Networks of N-Vinylpyrrolidone with (di)Methacrylates as Precursors of Ecological Molecular Imprinted Polymers by Kurmaz, Svetlana V., Fadeeva, Natalia V., Gorshkova, Anna I., Kurochkin, Sergey A., Knerelman, Eugenia I., Davydova, Galina I., Torbov, Vladimir I., Dremova, Nadezhda N., Konev, Dmitry V., Kurmaz, Vladimir A., Ignatiev, Vladislav M., Emelyanova, Nina S.

“…Mesoporous polymer networks were prepared via the cross-linking radical copolymerization of non-toxic hydrophilic N-vinylpyrrolidone (VP) with triethylene…”
Get full text

A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT) by Demidov, Lev, Kharkevich, Galina, Petenko, Natalia, Moiseenko, Vladimir, Protsenko, Svetlana, Semiglazova, Tatiana, Zimina, Anastasia, Kovalenko, Nadezhda, Fadeeva, Natalia, Kirtbaya, Dmitry, Belogortsev, Igor, Tantsyrev, Denis, Odintsova, Svetlana, Nesterova, Alfia, Vorontsova, Karina, Makarycheva, Yulia, Linkova, Yulia, Zinkina-Orikhan, Arina, Siliutina, Anna, Sorokina, Irina, Liaptseva, Daria, Chistyakov, Vladimir, Lutsky, Anton

“…Prolgolimab is the first Russian PD-1 inhibitor approved for the first-line treatment of unresectable or metastatic melanoma and advanced non-small cell lung…”
Get full text

399 Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial by Harris, Dean, Brungs, Daniel, Ladwah, Rahul, Mant, Andrew, McGrath, Margaret, Tazbirkova, Andrea, Akopov, Andrey, Fadeeva, Natalia, Kasparov, Boris, Kovalenko, Nadezhda, Kozlov, Vadim, Moiseenko, Fedor, Oschepkov, Vasiliy, Koralewski, Piotr, Kowalski, Dariusz, Lugowska, Iwona, Charoentumn, Chaiyut, Dechaphunkul, Arunee, Sriuranpong, Virote, Oliviero, James, Clingan, Philip

“…BackgroundCosibelimab is a high affinity, fully-human IgG1 monoclonal antibody that directly binds to programmed death ligand-1 (PD-L1) and blocks its…”
Get full text

Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study by Zhukova, Liudmila G., Bolotina, Larisa V., Dvornichenko, Victoria V., Fadeeva, Natalia V., Ganshina, Inna P., Grechukhina, Katerina S., Hasanova, Alfiya I., Kislov, Nikolay V., Kudryavtsev, Igor Yu, Manikhas, Alexey G., Musaeva, Natalia E., Nizhegorodtseva, Alexandra A., Sadikova, Olga E., Sakaeva, Dina D., Snegovoy, Anton V., Stroyakovskiy, Daniil L., Tjulandin, Sergei A., Trishkina, Ekaterina A., Vladimirova, Liubov Iu, Volkov, Nikita M., Kostalanova, Yulia V.

“…Background. The use of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in combination with endocrine therapy is a key initial treatment for advanced…”
Get full text

Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases receiving cytotoxic therapy: results of LEGERITY, a multicenter retrospective-and-prospective observational post-marketing study by Nesterova, Ekaterina S., Saydullaeva, Aleksandra F., Sherstnev, Dmitry G., Shelekhova, Tatiana V., Klitochenko, Tatiana Yu, Khusainova, Gulnara N., Lysenko, Irina B., Lyalina, Irina S., Demchenkova, Marina V., Orlova, Svetlana A., Proydakov, Andrei V., Betrozova, Мadina V., Fadeeva, Natalia V., Gofman, Alina A., Marchenko, Yana M., Voloshin, Sergey V., Pashneva, Elena A., Sarzhevskiy, Vladislav O., Babicheva, Alina R., Bondareva, Irina B., Glonina, Natalia N., Ishchanov, Damir G., Poddubnaya, Irina V.

“…Aim. To evaluate the effectiveness and safety of Extimia® BIOCAD (international non-proprietary name: empegfilgrastim) to reduce the incidence and duration of…”
Get full text

Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON by Tryakin, Alexey A., Fedyanin, Mikhail Yu, Moiseenko, Fedor V., Mironov, Oleg V., Stroyakovskiy, Daniil L., Sokolov, Nikolai Iu, Orlova, Svetlana A., Mantsyrev, Evgenii O., Sultanbaev, Alexander V., Teterich, Antonina A., Babina, Kseniia G., Yukalchuk, Denis Yu, Borzyanitsa, Stanislav M., Isyangulova, Alina Z., Saidullaeva, Aleksandra F., Chernova, Yuliia A., Bobrova, Elvira A., Fadeeva, Natalia V., Chobanu, Dmitrii Yu

“…Aim. To evaluate the safety and efficacy of long-term continuous use of Avegra BIOCAD (international nonproprietary name INN: bevacizumab) as a targeted…”
Get full text

Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases who receive cytotoxic therapy: results of LEGERITY, the second interim analysis of multicenter retrospective-and-prospective observational post-marketing study by Nesterova, Ekaterina S., Saydullaeva, Aleksandra F., Sherstnev, Dmitry G., Shelekhova, Tatiana V., Klitochenko, Tatiana Y., Khusainova, Gulnara N., Lysenko, Irina B., Lyalina, Irina S., Demchenkova, Marina V., Orlova, Svetlana A., Proydakov, Andrei V., Betrozova, Madina V., Fadeeva, Natalia V., Gofman, Alina A., Marchenko, Yana M., Voloshin, Sergey V., Pashneva, Elena A., Sarzhevskiy, Vladislav O., Ishchanov, Damir G., Poddubnaya, Irina V.

“…Aim. To assess effectiveness and safety of Extimia BIOCAD (INN: empegfilgrastim) used to decrease the rate and duration of neutropenia, the rate of febrile…”
Get full text

Multistability, quasiperiodicity and chaos in a self-oscillating ring dynamical system with three degrees of freedom based on the van der Pol generator by Astakhov, Sergey, Astakhov, Oleg, Fadeeva, Natalia, Astakhov, Vladimir

“…•Bifurcation mechanism for the emergence of multistability;•Quasiperiodic self-sustained oscillations;•Transition to chaos through the doublings of tori. In…”
Get full text

Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer by Govindan, Ramaswamy, Szczesna, Aleksandra, Ahn, Myung-Ju, Schneider, Claus-Peter, Gonzalez Mella, Pablo Fernando, Barlesi, Fabrice, Han, Baohui, Ganea, Doina Elena, Von Pawel, Joachim, Vladimirov, Vladimir, Fadeeva, Natalia, Lee, Ki Hyeong, Kurata, Takayasu, Zhang, Li, Tamura, Tomohide, Postmus, Pieter E, Jassem, Jacek, O'Byrne, Kenneth, Kopit, Justin, Li, Mingshun, Tschaika, Marina, Reck, Martin

“…Purpose Patients with squamous non-small-cell lung cancer (NSCLC) have poor prognosis and limited treatment options. This randomized, double-blind, phase III…”
Get full text

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study by Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

“…Immunotherapy with immune checkpoint inhibitors combined with an anti-angiogenic tyrosine-kinase inhibitor (TKI) has been shown to improve overall survival…”
Get full text

Some new and poorly known nematode species from the Sea of Japan by Fadeeva, Natalia, Mordukhovich, Vladimir

“…Diplopeltula tchesunovi sp. nov., Diplopeltoides holovachovi sp. nov. are described from the Sea of Japan from a depth of 1473m. D. tchesunovi sp. nov. is…”
Get full text

Comic art as a way to highlight current environmental issues by Mozhegova Irina Stanislavovna, Fadeeva Natalia Yuvenalievna

“…The article analyses satirical and humorous ideas in the French language covering current environmental issues. Special attention is paid to the description of…”
Get full text

Free-living marine nematodes of Desmodorella and Zalonema (Nematoda: Desmodoridae) with description of two new species from the deep sea of the North Western Pacific by Fadeeva, Natalia, Mordukhovich, Vladimir, Zograf, Julia

“…Examination of material recently collected by the German-Russian deep-sea expeditions has revealed that new species occur regularly in macro- and meiobenthic…”
Get more information

New deep-sea large free-living nematodes from macrobenthos in the Kuril–Kamchatka Trench (the North-Western Pacific) by Fadeeva, Natalia, Mordukhovich, Vladimir, Zograf, Julia

Get full text

Final results of a phase II trial of prolgolimab with platinum-based therapy and bevacizumab in patients with advanced cervical cancer by Fogt, Sergey, Andabekov, Timur, Shamsutdinova, Yana, Dvorkin, Mikhail, Artamonova, Elena, Chistyakov, Valerii, Zukov, Ruslan, Moiseenko, Vladimir, Nechaeva, Marina, Odintsova, Svetlana, Fadeeva, Natalia, Kislov, Nikolai, Tantsyrev, Denis, Tjulandin, Sergei, Fomin, Eugeniy, Linkova, Iuliia, Zinkina-Orikhan, Arina, Shustova, Mariia, Zhukova, Lyudmila

“…5536 Background: Here we present the final results of single-arm phase II CAESURA (NCT03912402) study of prolgolimab (anti-PD-1 antibody) with platinum doublet…”
Get full text

Revision of the genus Campylaimus (Diplopeltidae, Nematoda) with description of four new species from the Sea of Japan by Fadeeva, Natalia, Mordukhovich, Vladimir, Zograf, Julia

“…Four new Campylaimus species are described from the deep-sea sediments of the Sea of Japan at depths of about 500‒3400 m. Campylaimus orientalis sp. nov. is…”
Get more information

The effectiveness and safety of eribulin therapy in HR-positive HER2-negative metastatic breast cancer post-CDK4/6 inhibitor therapy in Russian clinical practice by Kolyadina, Irina Vladimirovna, Bolotina, Larisa, Zhukova, Lyudmila, Vladimirova, Liubov Yu, Sultanbaev, Alexander, Karabina, Elena, Ganshina, Inna, Ovchinnikova, Elena, Kolyadina, Irina Vladimirovna, Antonova, Galina, Volkonsky, Mikhail, Kolokolov, James, Zueva, Elena, Akopyan, I, Fadeeva, Natalia, Evstigneeva, Irina, Orlova, Svetlana, Vasilevskaya, Anna, Shalaeva, Oxana, Shirokova, Oxana

“…Abstract only e13035 Background: EMPOWER trial demonstrated the benefit of eribulin administrated post CD4/6i in patients (pts) with HR+ HER2-negative…”
Get full text

Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09) by Tannir, Nizar M, Formiga, Maria Nirvana, Penkov, Konstantin, Kislov, Nikolay, Vasiliev, Aleksandr, Gunnar Skare, Nils, Hong, Walter, Dai, Stanley, Tang, Lily, Qureshi, Anila, Zalevsky, Jonathan, Tagliaferri, Mary A, George, Daniel, Agarwal, Neeraj, Pal, Sumanta

“…Bempegaldesleukin (BEMPEG) is a pegylated interleukin (IL)-2 cytokine prodrug engineered to provide controlled and sustained activation of the clinically…”
Get full text